Asset
PAMIPARIB
BEONE MEDICINES LTD. AMERICAN DEPOSITARY SHARES
Revenue
No revenue reported in loaded filings.
Clinical trials (11)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03150862 | phase1_2 | completed | 2017-07-24 | 2021-03-17 | BeiGene USA, Inc. | A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma |
| NCT03575065 | phase2 | completed | 2018-06-22 | 2020-10-09 | BeiGene | Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China |
| NCT03519230 | phase3 | active_not_recruiting | 2018-05-14 | 2025-12-01 | BeiGene | Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer |
| NCT02361723 | phase1 | completed | 2014-07-03 | 2019-09-03 | BeiGene | Phase 1a/1b BGB-290 for Advanced Solid Tumors. |
| NCT03427814 | phase2 | completed | 2018-07-03 | 2020-06-18 | BeiGene | Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer |
FDA applications (0)
This company has no applications containing this asset.